On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Physiogenex SAS's own share of each project, not the project's full budget.
- FP7 (2007 to 2013)€121k · 1 project
Projects
1 EU-funded project, newest first. Each links to the official record.
- ADAPTPartner
Adipokines as Drug Targets to Combat Adverse Effects of Excess Adipose Tissue
FP7 (2007 to 2013) · 2008–2012 · Project on CORDIS ↗
€121ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Institut National de la Sante et de la Recherche MedicaleFrance · 1 shared project
- Karolinska InstitutetSweden · 1 shared project
- Charite - Universitaetsmedizin BerlinGermany · 1 shared project
- Stockholms UniversitetSweden · 1 shared project
- Univerzita KarlovaCzech Republic · 1 shared project
- Medizinische Hochschule HannoverGermany · 1 shared project
- Universite Pierre et Marie Curie - Paris 6France · 1 shared project
- Deutsche Diabetes Forschungsgesellschaft eVGermany · 1 shared project
- Mabtech ABSweden · 1 shared project
- Molecular Extended Distribution In Information TechnologyFrance · 1 shared project
- Laboratoire GlaxosmithklineFrance · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- medicinal chemistry
- obesity
- public health
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.